medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-11-166-169medsovet-1935Research ArticleЭндокринологияEndocrinologyРОЛЬ САМОКОНТРОЛЯ ГЛИКЕМИИ В ПРОФИЛАКТИКЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМGLYCAEMIA SELF-CONTROL ROLE IN PREVENTION OF CARDIOVASCULAR DISEASES IN DIABETES MELLITUS PATIENTSШацкаяО. А.ShatskayaО. A.

Кандидат медицинских наук.

Москва

PhD in medicine.

Moscow

КухаренкоС. С.KukharenkoS. S.

Кандидат медицинских наук.

Москва

PhD in medicine.

Moscow

Эндокринологический научный центр Минздрава РоссииРоссияEndocrinology Scientific Center of the Ministry of Health of RussiaRussian Federation201704072017011166169Copyright © Шацкая О.А., Кухаренко С.С., 20172017Шацкая О.А., Кухаренко С.С.Shatskaya О.A., Kukharenko S.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1935

В настоящее   время  доказано,  что гипогликемия  является независимым   фактором  риска сердечно-сосудистых  событий у больных сахарным диабетом. В статье рассматриваются потенциальные механизмы воздействия гипогликемии на сердечно-сосудистую систему и вопросы самоконтроля гликемии при сахарном диабете.

Currently glycaemia is proved to be an independent risk factor of cardiovascular events in diabetes mellitus patients. The article considers potential hypoglycaemia action mechanisms on the cardiovascular system and glycaemia self-control issues in diabetes mellitus.

сахарный диабетгипогликемиясердечно-сосудистый рискконтроль гликемииdiabetes mellitushypoglycaemiacardiovascular riskglycaemia controlReferencesОфициальный сайт Всемирной Организации Здравоохранения [Электронный ресурс]. URL: www.who.int/ru/.Официальный сайт Всемирной Организации Здравоохранения [Электронный ресурс]. URL: www.who.int/ru/.Emerging Risk Factors Collaboration. Seshasai SRK, Kaptoge S, Thompson A et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med, 2011, 364: 829–841. doi: 10.1056/NEJMoa1008862.Emerging Risk Factors Collaboration. Seshasai SRK, Kaptoge S, Thompson A et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med, 2011, 364: 829–841. doi: 10.1056/NEJMoa1008862.Bedenis R, Price AH, Robertson CM et al. Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. Diabetes Care, 2014, 37: 3301–3308. doi: 10.2337/dc14-0908.Bedenis R, Price AH, Robertson CM et al. Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. Diabetes Care, 2014, 37: 3301–3308. doi: 10.2337/dc14-0908.McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care, 2012, 35: 1897–1901. doi: 10.2337/dc11-2054.McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care, 2012, 35: 1897–1901. doi: 10.2337/dc11-2054.Mellbin LG, Ryd´en L, Riddle MC et al. ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J, 2013, 34: 3137–3144. doi: 10.1093/eurheartj/eht332.Mellbin LG, Ryd´en L, Riddle MC et al. ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J, 2013, 34: 3137–3144. doi: 10.1093/eurheartj/eht332.ZoungasS, Patel A, Chalmers J et al. ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med, 2010, 363: 1410–1418. doi: 10.1056/NEJMoa1003795.ZoungasS, Patel A, Chalmers J et al. ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med, 2010, 363: 1410–1418. doi: 10.1056/NEJMoa1003795.Connelly KA, Yan AT, Leiter LA, Bhatt DK, Verta S. Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus. Circulation, 2015, 132: 2345–2350. doi: 10.1161/CIRCULATIONAHA.115.015946.Connelly KA, Yan AT, Leiter LA, Bhatt DK, Verta S. Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus. Circulation, 2015, 132: 2345–2350. doi: 10.1161/CIRCULATIONAHA.115.015946.Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ, 2013, 347: f4533. doi: 10.1136/bmj.f4533.Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ, 2013, 347: f4533. doi: 10.1136/bmj.f4533.Tanenberg RJ, Newton CA, Drake AJ., III Confirmation of hypoglycemia in the «dead-in-bed» syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract, 2010, 16: 244–248. doi: 10.4158/EP09260.CR.Tanenberg RJ, Newton CA, Drake AJ., III Confirmation of hypoglycemia in the «dead-in-bed» syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract, 2010, 16: 244–248. doi: 10.4158/EP09260.CR.Cryer PE. Death during intensive glycemic therapy of diabetes: Mechanisms and implications. Am J Med, 2011, 124: 993–6. doi: 10.1016/j.amjmed.2011.08.008.Cryer PE. Death during intensive glycemic therapy of diabetes: Mechanisms and implications. Am J Med, 2011, 124: 993–6. doi: 10.1016/j.amjmed.2011.08.008.Duckworth W, Abraira C, Moritz T, Reda D, VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009, 360: 129–139. doi: 10.1056/NEJMoa0808431.Duckworth W, Abraira C, Moritz T, Reda D, VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009, 360: 129–139. doi: 10.1056/NEJMoa0808431.ACCORD Study Group, Gerstein HC, Miller ME, G enuth S at al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med, 2011, 364: 818–828. doi: 10.1056/NEJMoa1006524.ACCORD Study Group, Gerstein HC, Miller ME, G enuth S at al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med, 2011, 364: 818–828. doi: 10.1056/NEJMoa1006524.Patel A, MacMahon S, Chalmers J, Neal B at al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358: 2560–2572. doi: 10.1056/NEJMoa0802987.Patel A, MacMahon S, Chalmers J, Neal B at al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358: 2560–2572. doi: 10.1056/NEJMoa0802987.Seaquist ER, Anderson J, Childs B, Cryer P at al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care, 2013, 36: 1384–1395. doi: 10.2337/dc12-2480.Seaquist ER, Anderson J, Childs B, Cryer P at al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care, 2013, 36: 1384–1395. doi: 10.2337/dc12-2480.Tsujimoto T, Yamamoto-Honda R, Kajio H, et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care, 2014, 37: 217–225. doi: 10.2337/dc13-0701.Tsujimoto T, Yamamoto-Honda R, Kajio H, et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care, 2014, 37: 217–225. doi: 10.2337/dc13-0701.Landstedt-Hallin L, Englund A, Adamson U, LinsPE. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med, 1999, 246: 299–307. PMID: 10475998.Landstedt-Hallin L, Englund A, Adamson U, LinsPE. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med, 1999, 246: 299–307. PMID: 10475998.Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA, 2003, 289: 2120–2127. doi: 10.1001/jama.289.16.2120.Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA, 2003, 289: 2120–2127. doi: 10.1001/jama.289.16.2120.Nordin C. The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia. Acta Diabetol, 2014, 51: 5–14. doi: 10.1007/s00592-013-0528-0.Nordin C. The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia. Acta Diabetol, 2014, 51: 5–14. doi: 10.1007/s00592-013-0528-0.Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z. Impairment of human ether-`a-go-gorelated gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem, 2003, 278: 10417–10426. doi: 10.1074/jbc.M211044200.Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z. Impairment of human ether-`a-go-gorelated gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem, 2003, 278: 10417–10426. doi: 10.1074/jbc.M211044200.Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes, 2005, 54: 2430–2435. PMID: 16046311.Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes, 2005, 54: 2430–2435. PMID: 16046311.Bedenis R, Price AH, Robertson CM, Morling JR, Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. Diabetes Care, 2014, 37: 3301–3308. doi: 10.2337/dc14-0908.Bedenis R, Price AH, Robertson CM, Morling JR, Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. Diabetes Care, 2014, 37: 3301–3308. doi: 10.2337/dc14-0908.Sommerfield AJ, Wilkinson IB, Webb DJ, Frier B M. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab, 2007, 293: E1274–E1279. doi: 10.1152/ajpendo.00114.2007.Sommerfield AJ, Wilkinson IB, Webb DJ, Frier B M. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab, 2007, 293: E1274–E1279. doi: 10.1152/ajpendo.00114.2007.Healy SJ, Dungan KM. Monitoring Glycemia in Diabetes. Med Clin N Am, 2015, 99: 35–45. doi: 10.1016/j.mcna.2014.08.017.Healy SJ, Dungan KM. Monitoring Glycemia in Diabetes. Med Clin N Am, 2015, 99: 35–45. doi: 10.1016/j.mcna.2014.08.017.Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 8-й выпуск. М.: УП ПРИНТ, 2017.Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 8-й выпуск. М.: УП ПРИНТ, 2017.Официальный сайт Международной организации по стандартизации [Электронный ресурс]. URL: http://www.iso.org.Официальный сайт Международной организации по стандартизации [Электронный ресурс]. URL: http://www.iso.org.

The authors declare that there are no conflicts of interest present.